Business
Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care
Through Omada’s GLP-1 Flex Care offering, employers gain a new flexible option to connect employees with anti-obesity medication, virtual care, and lifestyle
About this update from Omada Health, Inc.
[{"type":"text","content":"Through Omada’s GLP-1 Flex Care offering, employers gain a new flexible option to connect employees with anti-obesity medication, virtual care, and lifestyle support\nSAN FRANCISCO, March 05, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, today announced GLP-1 Flex Care, a new offering that will support employers looking to increase access to GLP-1 medications for obesity, including clinical evaluation, prescribing, and ongoing medical guidance and oversight. Members purchase their medications independently through cash-pay channels, helping employers limit their direct exposure to medication costs. Employee demand for GLP-1 medications continues to grow, but for many employers, the economics of full coverage remain out of reach.1 The majority of employers consider managing GLP-1 coverage and cost important,2 but finding a financially sustainable path for access can be difficult. Meanwhile, employees are increasingly turning to fragmented cash-pay channels3 that lack coordinated medical oversight and provide little visibility into clinical best practices or sustainable outcomes. GLP-1 Flex Care is built for this reality, giving employers a way to act now, on their terms. \"Employers shouldn't have to choose between providing the medication and obesity care their workforce needs to be healthy and protecting their bottom line,\" said Wei-Li Shao, President of Omada Health. \"GLP-1 Flex Care removes that tradeoff. It gives employers an affordable option they can offer today, one that keeps them in control of their spend while helping their employees get important medical oversight, prescribing, and lifestyle support.\" Through GLP-1 Flex Care, members can be evaluated for GLP-1 eligibility, have labs ordered, and receive prescriptions for FDA-approved GLP-1 medications. GLP-1 Flex Care will also provide ongoing clinical oversight including titration management, support with side-effects, nutrition and activity counseling, and discontinuation support. In-program providers will also work with each member to identify appropriate medications and cash-pay options based on their clinical profile and what they can afford, whether that's an injectable or an oral formulation. Members will independently purchase medications through established cash-pay channels while receiving Omada's ...